The DOI matches its Crossref record; 66 of the 74 references it cites were found in a registry or an index; 11 of the 83 sources its claims cite were checked for support.
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men
Open accessAbstract
To elucidate the role of leptin in regulating neuroendocrine and metabolic function during an acute fast, six to eight healthy, lean men were studied under four separate conditions: a baseline fed state and three 72-hour fasting studies with administration of either placebo, low-dose recombinant-methionyl human leptin (r-metHuLeptin), or replacement-dose r-metHuLeptin designed to maintain serum leptin at levels similar to those in the fed state. Replacement-dose r-metHuLeptin administered during fasting prevents the starvation-induced changes in the hypothalamic-pituitary-gonadal axis and, in part, the hypothalamic-pituitary-thyroid axis and IGF-1 binding capacity in serum. Thus, in normal men, the fall in leptin with fasting may be both necessary and sufficient for the physiologic adaptations of these axes, which require leptin levels above a certain threshold for activation. In contrast to findings in mice, fasting-induced changes in the hypothalamic-pituitary-adrenal, renin-aldosterone, and growth hormone-IGF-1 axes as well as fuel utilization may be independent of leptin in humans. The role of leptin in normalizing several starvation-induced neuroendocrine changes may have important implications for the pathophysiology and treatment of eating disorders and obesity.
Overview
CoChat Summary
## TL;DR
In six healthy lean men, 72-hour fasting drove leptin down to about 10% of baseline, and replacement-dose r-metHuLeptin restored leptin to physiologic levels. Leptin replacement prevented fasting-induced suppression of the HPG axis and partly the HPT axis, but did not meaningfully change fasting effects on the HPA axis, renin-aldosterone system, GH/IGF-1, or fuel utilization.
## Key findings
- Fasting for 72 hours reduced serum leptin to about 10% of baseline and lowered leptin mass, amplitude, pulsatility production rate, mean concentration, and integrated area; low-dose r-metHuLeptin raised leptin to about 30% of baseline, while replacement-dose r-metHuLeptin fully restored leptin to levels slightly above fed state but within the physiologic range for lean men.
- Replacement-dose r-metHuLeptin fully restored testosterone levels and LH pulsatility characteristics during fasting; the paper reports a significant treatment effect for testosterone changes (P = 0.007) and a significant difference in LH response to GnRH (P = 0.028), with fed-state GnRH AUC 2,395.46 ± 575.83 and fasting/replacement-dose AUC 2,874.84 ± 391.49.
- Replacement-dose r-metHuLeptin prevented the fasting-induced suppression of TSH pulsatility and produced a slight increase in FT4, but did not change fasting-induced decreases in T3 or increases in rT3; fasting decreased T3 by about 30% and TSH integrated area by over 70%.
- Leptin replacement did not alter fasting-induced changes in GH pulsatility, free IGF-1, cortisol, PRA/aldosterone, or the major fasting shift in fuel utilization; fasting increased RMR, lowered RQ, decreased carbohydrate utilization by over 75%, increased fat utilization by 45%, and increased protein utilization by 50%.
- During refeeding, replacement-dose r-metHuLeptin only tended to lower calorie intake; the difference was not significant.
## Methods
- The study was a clinical intervention in eight healthy lean men, with six evaluable subjects reported; mean age was 23.5 ± 1.3 years and mean BMI 24.0 ± 0.4 kg/m².
- Each subject underwent four conditions: baseline fed state, 72-hour fasting + placebo, 72-hour fasting + low-dose r-metHuLeptin, and 72-hour fasting + replacement-dose r-metHuLeptin; placebo and low-dose leptin admissions were randomized and double-blinded.
- Main analyses included serial hormone sampling, 24-hour pulse analysis for leptin/LH/TSH/GH, stimulation tests with GnRH and TRH, body composition by DEXA, resting metabolic rate measurement, urine catecholamines/nitrogen, and repeated-measures ANOVA with post hoc tests.
## Limitations
- The study was small: only six evaluable subjects were analyzed, and one subject could not complete the fasting/low-dose admission; the paper itself notes that some nonsignificant results may reflect the relatively small n.
- Only healthy young lean men were studied, so the findings may not generalize to women, overweight/leptin-resistant subjects, or clinical low-leptin states; this limitation is stated in the discussion.
- The text makes evident that several figures/tables are hard to interpret from the provided extract because many table values are garbled; textual conclusions are still clear, but some detailed numeric results are not readable in this copy.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
10 Valid · 1 Not valid · 43 Not checked · 145 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In humans, as in mice, congenital absence of leptin or functional leptin deficiency due to inactivating mutations of the leptin receptor causes severe obesity accompanied by neuroendocrine abnormalities (2-4, 22).”
What the sources say
- Supportedcites [2] source
This source supports the congenital leptin-deficiency part of the multi-citation sentence, not the separate leptin-receptor mutation part. Its Abstract reports severe obesity and hyperinsulinaemia in two leptin-deficient children, and the endocrine biochemistry table records mildly elevated TSH in both (page numbers unavailable in our copy). (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [3] source
- Not checked — no full text of the sourcecites [4] source
- Not checked — no full text of the sourcecites [22] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These findings are in contrast to the effect of leptin administration on increase natriuresis (49, 50) and sympathetic activity (51) in normal, nonobese leptin-resistant Zucker rats (51).”
What the sources say
- Not checked — no full text of the sourcecites [49] Villarreal, 1998, Am. J. Physiol. source
- Not checked — no full text of the sourcecites [50] Jackson, 1997, Am. J. Physiol. source
- Partly supportedcites [51] sourceExperimental — accuracy not yet measured
The Results (A-SNA) report that leptin increased renal and brown-adipose sympathetic nerve activity in lean Zucker rats. But the Abstract and Discussion identify obese Zucker rats as leptin-resistant and report blunted responses in them, contrary to describing the nonobese rats as leptin-resistant. The sentence cites other sources, not this paper, for natriuresis. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“total production rate correlated highly with mass ( r = 0.684, P < 0.001)”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Prolonged (72-hour) fasting suppresses serum leptin levels out of proportion to the change in fat mass, and r-metHuLeptin administration in replacement doses restores leptin levels .”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The relative changes in testosterone levels were significantly different between admissions by ANOVA ( P = 0.007).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
112 more claims
Create a free account to see all 199 claims and every source verdict.
- Probably not a substantial claim. 50
- It may state two separate claims as one. 51
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, this mechanism may not be directly applicable to humans because leptin does not activate this system in human subjects [26,27].”
From Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women (2011) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We fi rst showed that acutely depriving mice and then healthy men of energy by caloric restriction resulted in relative leptin de fi ciency and neuroendocrine abnormalities affecting the gonadal and thyroid axes, and these abnormalities were prevented with recombinant methionyl human leptin (metreleptin) replacement (11, 12).”
From Leptin is an effective treatment for hypothalamic amenorrhea (2011) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We fi rst showed that acutely depriving mice and then healthy men of energy by caloric restriction resulted in relative leptin de fi ciency and neuroendocrine abnormalities affecting the gonadal and thyroid axes, and these abnormalities were prevented with recombinant methionyl human leptin (metreleptin) replacement (11, 12).”
From Leptin is an effective treatment for hypothalamic amenorrhea (2011) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that short-term starvation of mice (11) and humans (12, 21, 22) results in hypoleptinemia and alterations in the reproductive, thyroid, and growth hormone axes, which are normalized with exogenous administration of leptin.”
From Leptin is an effective treatment for hypothalamic amenorrhea (2011) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Experimental studies in healthy volunteers during food deprivation showed that administration of leptin may partially reverse this process [75].”
From An update on non-thyroidal illness syndrome (2021) · cites this paper as [75]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationCongenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Nutritional Regulation of the Insulin-Like Growth Factors*
THISSEN, J.-P., KETELSLEGERS, J.-M., & UNDERWOOD, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,579
Nutritional regulation of the insulin-like growth factors
Thissen, J. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.1.80 · Cited by 1,578
Chehab, F. F., Lim, M. E., & Lu, R. (1996) · Nature Genetics · doi:10.1038/ng0396-318 · Cited by 1,476
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,320
Self-citation
Research works printed but not linked: 1
- Villarreal, 1998, Am. J. Physiol., 275, R2056
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00270.x · Cited by 1,442
Leptin and Obesity: Role and clinical implication.
Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A. J., Gojobori, T., & Isenovic, E. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.585887 · Cited by 1,121
Recombinant human leptin in women with hypothalamic amenorrhea
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040388 · Cited by 908
Self-citationObesity and leptin resistance: distinguishing cause from effect
Myers, M. G., Leibel, R. L., Seeley, R. J., & Schwartz, M. W. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.002 · Cited by 901
Metadata
- Authors
- Chan, J. L., Heist, K., DePaoli, A. M., Veldhuis, J. D., & Mantzoros, C. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Amgen (United States) (US)
- Mayo Clinic (US)
- Corresponding author
- Mantzoros, Christos S.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-05-01
- Volume
- 111
- Issue
- 9
- Pages
- 1409-1421
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC154448
- OpenAlex
- W4233349015
- Cited by
- 697
- References
- 74
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 34 · 2023: 27 · 2022: 23 · 2021: 31 · 2020: 33 · 2019: 34 · 2018: 29 · 2017: 28 · 2016: 34 · 2015: 31 · 2014: 34 · 2013: 31 · 2012: 35
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Deutsches Krebsforschungszentrum
- National Institutes of Health (5k30hl004095-05, RR 01032)
- U.S. Public Health Service (R0-158785)
- National Heart, Lung, and Blood Institute (K30-HL004095, K30HL04095)
- National Institute of Diabetes and Digestive and Kidney Diseases (58785)
- National Center for Research Resources (M01RR001032)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- leptin, short-term starvation, fasting, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-thyroid axis, hypothalamic-pituitary-adrenal axis, renin-aldosterone system, growth hormone/IGF-1 axis, recombinant human leptin, neuroendocrine adaptation, metabolic adaptation, fuel utilization, eating disorders, obesity
- MeSH terms
- Adult, Body Weight, Double-Blind Method, Eating, Energy Metabolism, Epinephrine, Fasting, Homeostasis, Humans, Hydrocortisone, Insulin-Like Growth Factor I, Luteinizing Hormone, Male, Neurosecretory Systems, Testosterone, Thyroid Hormones, Human Growth Hormone, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. https://app.cochat.ai/papers/10.1172/jci17490
- The paper
- Chan, J. L., Heist, K., DePaoli, A. M., Veldhuis, J. D., & Mantzoros, C. S. (2003). The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation. https://doi.org/10.1172/jci17490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



